EN
中文 EN
Newsroom
Company News
Media Report
Company News
More
2024-06-25
CanSinoBIO Executives Talk with WHO Experts on the Development Progress of Polio Vaccines
CanSinoBIO CSO Shares the Latest Results of the Company's Globally Innovative Pneumococcal Vaccine
2024-04-26
CanSinoBIO Initiates Phase Ⅲ Clinical Trial of Group ACYW135 Meningococcal Conjugate Vaccine Menhycia® in Indonesia
2024-03-25
CanSinoBIO and SPIMACO Forge Strategic Partnership to Advance Accessibility of Cutting-Edge Vaccines
2023-12-18
CanSinoBIO Kicks-off the Polio VLP Vaccine Cooperation
2023-12-04
CanSinoBIO will be included in the MSCI China All Share Small Cap Index
2023-11-17
Media Report
More
CanSinoBIO Secures Further Funding from the Bill & Melinda Gates Foundation
More
CanSinoBIO Reports Outstanding H1 2024 Performance
More
Ebola outbreak in Congo 'largely contained', says WHO
More